GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81770616, 5172009)
- Natural Science Foundation of Beijing Municipality (81770616, 5172009)
This publication has 56 references indexed in Scilit:
- Stem cells isolated from adipose tissue of obese patients show changes in their transcriptomic profile that indicate loss in stemcellness and increased commitment to an adipocyte-like phenotypeBMC Genomics, 2013
- Regulation of mitochondrial biogenesis and PGC-1α under cellular stressMitochondrion, 2013
- Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy numberBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2012
- Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory networkBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Fatty Acid Metabolism in the Liver, Measured by Positron Emission Tomography, Is Increased in Obese IndividualsGastroenterology, 2010
- Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent modelJournal of Hepatology, 2010
- Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivoGut, 2008
- Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytesHepatology, 2007
- Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivoBiochemical and Biophysical Research Communications, 2005
- Nuclear Receptor Signaling and Cardiac EnergeticsCirculation Research, 2004